查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018521

疝氣修補器材市場：2026年至2032年全球市場預測（依產品類型、疝氣類型、手術方法、病患群體和最終用戶分類）

Hernia Repair Devices Market by Product, Hernia Type, Procedure Type, Patient Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，疝氣修補器材市場價值將達到 69.3 億美元，到 2026 年將成長至 74 億美元，到 2032 年將達到 113.6 億美元，複合年成長率為 7.31%。

主要市場統計數據
基準年 2025 69.3億美元
預計年份：2026年 74億美元
預測年份 2032 113.6億美元
複合年成長率 (%) 7.31%

對不斷發展的疝氣修補器材市場進行全面概述，重點在於臨床因素、材料創新、報銷方案和相關人員的優先事項。

疝氣修補器材的市場趨勢取決於外科技術的進步、材料科學的發展以及醫療服務模式的演變。如今，外科醫生、負責人和器械製造商都面臨著一個以微創手術、以患者為中心的治療效果以及成本控制為決策促進因素的環境。隨著外科團隊仔細審查網片和縫線的使用適應症並評估固定技術，主要的臨床挑戰仍然是實現持久修復，最大限度地減少併發症並加速康復。同時，監管、上市後監測以及對長期生物相容性的日益關注也在影響產品研發的方向。

分析推動疝氣修補市場外科創新、材料進步、證據產生和供應鏈韌性的變革性因素。

疝氣修補器材的設計、應用和臨床評估正經歷著一場意義深遠的變化。首先，微創和機器人輔助手術的不斷發展改變了器械的規格。如今，研發人員優先考慮的是器械能否透過套管針輕鬆導入、能否在最大限度減少組織損傷的情況下實現牢固固定，以及能否與影像引導手術流程相容。其次，材料的創新正在重新定義長期的治療效果。混合網片、塗層合成網片和新一代生物基質致力於減少慢性疼痛、沾黏形成和感染風險，同時促進重建性組織重塑。

評估 2025 年關稅措施將如何重塑整個醫療保健系統中疝氣修復設備的籌資策略、供應鏈和成本動態。

關稅的實施可能會調整整個疝氣修補器械生態系統的籌資策略、成本結構和供應商關係。關稅調整通常會影響採購決策，促使醫療系統和經銷商重新審視其供應商組合，以降低整體成本的增加。反過來，製造商通常會考慮製造地的地域多元化、重組物流或進行本地組裝，以保持價格競爭力並確保患者能夠繼續獲得必要的醫療設備。這些商業舉措通常涉及重新談判契約，以優先考慮穩定的供應和可預測的價格。

為了指導策略優先排序，關鍵的細分見解至關重要，這些見解將醫療設備類型、臨床疝氣亞型、手術方法、患者人口統計特徵和醫療保健環境聯繫起來。

深入的市場細分有助於清楚了解不同醫療設備類別和患者群體中的應用模式和臨床決策。依產品類型分類，市場可分為固定裝置、網片和縫合線。網片可細分為生物網膜和合成網片，縫線則分為可吸收縫線和不可吸收縫線。這種分類系統揭示了不同的臨床路徑。例如，合成網片通常優先考慮抗張強度和耐用性，而生物網膜則適用於污染區域和組織再生場景。此外，固定裝置的選擇圖在確保牢固固定的同時，兼顧潛在的神經和組織刺激風險。依疝氣的類型分類，市場可分為股疝氣、食道裂孔疝氣、腹股溝疝氣和腹壁疝，其中腹壁疝氣可進一步細分為上腹疝氣、切口疝氣和臍疝氣。這些臨床亞型各有不同的復發風險、解剖限制和設備相容性要求，這會影響外科醫師的選擇和設備的設計。

全面深入的區域分析，揭示美洲、歐洲、中東和非洲以及亞太地區的趨勢如何影響監管、臨床和商業策略。

區域趨勢對監管路徑、報銷環境和臨床實踐模式有顯著影響，為市場參與企業創造了不同的機會和挑戰。在美洲，手術量和微創技術的廣泛應用與主導方以成本效益和價值為導向的採購模式並存。臨床醫生通常會在採用創新技術與改善可證實的治療效果之間尋求平衡，而在商業環境中，經久耐用且有可靠臨床證據和經濟案例研究支持的醫療器械更受青睞。在歐洲、中東和非洲，由於管理體制和醫療資金籌措模式的多樣性，技術應用的進展各不相同。一些市場正在快速採用先進的網片和機器人平台，而其他市場則優先考慮低成本、可靠的案例研究和本地製造夥伴關係關係，以擴大醫療服務的可及性。

競爭考察和公司層面的洞察揭示了成熟企業和創新企業如何協調臨床證據、供應鏈策略和商業模式，以實現永續的差異化。

疝氣修補器材市場的競爭動態由成熟的醫療設備製造商、專業外科網片公司以及靈活敏捷、技術驅動的新興參與企業組成。市場領導通常利用廣泛的商業化網路、與醫生的良好關係以及豐富的監管合規經驗來確保保險覆蓋和外科醫生的選擇。同時，小規模的創新者往往在材料科學的細分領域取得突破，或致力於提升手術操作的便利性。這些企業的策略性舉措包括：透過有針對性的收購來填補其網片產品系列的空白；與臨床研究聯盟合作以加速循證醫學證據的產生；以及投資於外科醫生培訓項目以縮短新產品上市週期。

為行業領導者提供切實可行的建議，以協調證據生成、外科醫生培訓、供應鏈韌性和商業性價值提案，從而確保永續的競爭力。

產業領導者應推動一系列合作舉措，以提升臨床可信度和商業性韌性。領導企業必須優先進行嚴謹的證據收集工作，包括療效比較研究和基於註冊登記的結果，以支持其關於降低復發率、緩解疼痛和增強抗感染能力的論點。同時，增加對外科醫生教育和培訓的投入，將透過減少實踐差異和支持可重複的結果，加速相關技術在大學醫院和社區醫院的推廣應用。在採購談判中，企業應提出綜合價值提案，整合臨床數據、治療成本效益分析和實施支持，以滿足醫療系統決策者的優先事項。

為了確保獲得可靠且可操作的見解，我們採用嚴格的調查方法，結合與關鍵相關人員的訪談、同行評審證據的整合以及專家檢驗。

本研究途徑整合了與關鍵相關人員的對話、系統性的文獻綜述以及臨床指南與真實臨床模式的三角檢驗，以提供可靠的見解。主要調查包括對不同專科的外科醫生、醫院採購經理、醫療設備研發主管和監管專家進行結構化訪談，以了解實際情況、未滿足的臨床需求以及推廣應用的障礙。次要調查著重於提取具有臨床意義的發現並確保方法的嚴謹性，其依據包括同行評審的臨床研究、專業學會指南、監管申報文件和公開的安全資訊。

總結整合：為了維持價值和促進採用，強調需要整合臨床證據、程序適用性和供應鏈彈性。

整體而言，疝氣修補器材領域正朝著材料創新、手術改進和價值主導商業化融合的方向發展。臨床醫生和醫療系統越來越期望醫療設備不僅要具備安全性和耐用性，還要能夠顯著改善病患體驗並提高後續資源利用率。隨著手術技術在開放性手術、腹腔鏡手術和機器人手術等不同平台上的多樣化發展，醫療設備的設計和支援服務也必須隨之調整，以提供穩定且可擴展的治療效果。同時，關稅調整和供應鏈波動等外部壓力凸顯了營運彈性和區域客製化策略的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 疝氣修補器材市場：依產品分類

  • 固定裝置
  • 網
    • 生物網膜
    • 複合網格
  • 縫合線
    • 吸收性
    • 不吸收

第9章 依疝氣類型分類的疝氣修補器材市場

  • 股疝氣
  • 食道裂孔疝
  • 腹股溝疝氣
  • 腹壁疝
    • 上腹疝
    • 切口疝
    • 臍疝氣

第10章 依手術方法分類的疝氣修補器械市場

  • 腹腔鏡手術
  • 開放性手術
  • 機器人手術

第11章 依病患類型分類的疝氣修補器材市場

  • 成人版
  • 兒童

第12章 疝氣修補器械市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章 疝氣修補器材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 疝氣修補器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 疝氣修補器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國疝氣修補器材市場

第17章：中國疝氣修補器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AbbVie Inc.
  • Aran Biomedical by Integer Holdings Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast A/S
  • CooperSurgical, Inc.
  • Cousin Surgery
  • Deep Blue Medical Advances, Inc.
  • Dolphin Sutures
  • Getinge AB
  • HERNIAMESH Srl
  • Hwainmedi Co., Ltd.
  • Insightra Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KATSAN Katgut Sanayi ve Tic. AS
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Momentis Surgical Ltd.
  • Novus Scientific AB
  • Olympus Corporation
  • Secant Group, LLC
  • Surgimatix, Inc.
  • TELA Bio, Inc.
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-A339DAEFA9CA

The Hernia Repair Devices Market was valued at USD 6.93 billion in 2025 and is projected to grow to USD 7.40 billion in 2026, with a CAGR of 7.31%, reaching USD 11.36 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.93 billion
Estimated Year [2026] USD 7.40 billion
Forecast Year [2032] USD 11.36 billion
CAGR (%) 7.31%

Comprehensive introduction to the evolving hernia repair devices landscape highlighting clinical drivers, materials innovation, reimbursement, and stakeholder priorities

The landscape of hernia repair devices sits at the intersection of advancing surgical technique, materials science, and evolving healthcare delivery models. Surgeons, procurement officers, and device manufacturers now operate in a climate where minimally invasive approaches, patient-centered outcomes, and cost containment drive decision-making. As surgical teams refine indications for mesh versus suture use and evaluate fixation technologies, the clinical imperative remains constant: durable repair with minimal complications and accelerated recovery. Concurrently, regulatory scrutiny, post-market surveillance, and heightened attention to long-term biocompatibility shape product development trajectories.

In this environment, strategic stakeholders must reconcile clinical efficacy with operational constraints. Hospitals and ambulatory centers prioritize throughput and safety, while payers emphasize value and comparative effectiveness. As a result, device innovators are increasingly focused on optimizing design for reproducible outcomes across open, laparoscopic, and robotic procedures, and aligning product claims with real-world evidence. The ensuing sections synthesize these forces and present an integrative view of the structural shifts, regional nuances, and actionable priorities that will influence clinical adoption and commercial pathways for hernia repair technologies.

Analysis of transformative forces accelerating procedural innovation, materials evolution, evidence generation, and supply chain resilience across hernia repair markets

Significant transformative shifts are reshaping how hernia repair devices are designed, adopted, and valued across care settings. First, the continued evolution of minimally invasive and robotic-assisted procedures has changed device specifications; developers now prioritize ease of deployment through trocars, secure fixation with minimal tissue trauma, and compatibility with image-guided workflows. Second, materials innovation is redefining long-term outcomes: hybrid meshes, coated synthetics, and next-generation biological matrices focus on reducing chronic pain, adhesion formation, and infection risk while promoting constructive remodeling.

Third, evidence generation has shifted from single-arm safety studies to comparative effectiveness and real-world registries, influencing clinician choice and payer coverage. Consequently, manufacturers invest more in post-market studies, registries, and health economics to substantiate value propositions. Fourth, supply chain resilience and manufacturing scalability have moved to the forefront after global disruptions, prompting strategic sourcing and regional production considerations. Finally, patient expectations and shared decision-making are increasingly central; patients seek transparency around recovery timelines, recurrence risks, and the trade-offs between mesh types and fixation approaches. Together, these shifts create an environment where technical differentiation, proven patient outcomes, and alignment with care pathways determine long-term competitiveness.

Evaluation of how tariff actions in 2025 could reshape procurement strategies, supply chains, and cost dynamics for hernia repair devices across healthcare systems

The imposition of tariffs can recalibrate procurement strategies, cost structures, and supplier relationships throughout the hernia repair device ecosystem. Tariff-driven adjustments typically influence sourcing decisions, with health systems and distributors reviewing supplier portfolios to mitigate increased landed costs. In response, manufacturers often explore geographic diversification of manufacturing, reconfiguration of logistics, or local assembly to preserve price competitiveness and maintain customer access to essential devices. These operational moves are frequently accompanied by renegotiated contracts that prioritize stable supply and predictable pricing.

Clinically, tariff effects can translate into procurement decisions that prioritize devices with comparably lower total delivered cost or those produced domestically, particularly for high-volume consumables such as fixation devices, mesh, and sutures. Regulatory and compliance teams must also assess labeling, CE or FDA equivalency documentation, and import classification to avoid unintended delays at customs. Moreover, incremental cost pressures may accelerate interest in reusable instrumentation or techniques that reduce dependence on imported single-use components. Importantly, tariff impacts reinforce the need for transparent supplier scorecards, scenario planning for reimbursement shifts, and strengthened dialogue among clinical, procurement, and supply chain leaders to sustain device availability without compromising clinical standards.

Key segmentation insights that interlink device type, clinical hernia subtypes, procedural approaches, patient demographics, and care settings to guide strategic prioritization

Insightful segmentation clarifies adoption patterns and clinical decision-making across device categories and patient populations. Based on product, the market is studied across fixation devices, mesh, and sutures, with mesh further parsed into biological mesh and synthetic mesh while sutures are distinguished between absorbable and non-absorbable types; this taxonomy reveals divergent clinical pathways, where synthetic meshes often prioritize tensile strength and durability while biological meshes are positioned for contaminated fields or tissue regeneration scenarios, and fixation device selection balances secure anchoring against potential nerve or tissue irritation. Based on hernia type, the market is studied across femoral hernia, hiatal hernia, inguinal hernia, and ventral hernia, while ventral hernia is further analyzed into epigastric hernia, incisional hernia, and umbilical hernia; these clinical subtypes carry distinct recurrence risks, anatomical constraints, and device compatibility requirements that influence surgeon preference and device design.

Based on procedure type, the market is studied across laparoscopic surgery, open surgery, and robotic surgery, each presenting unique handling characteristics and instrumentation needs that shape product adaptation and training investments. Based on patient type, the market is studied across adult and pediatric populations, highlighting divergent anatomical considerations, long-term safety expectations, and device sizing or material choices. Based on end user, the market is studied across ambulatory surgical centers, clinics, and hospitals, reflecting variability in purchasing processes, procedural volumes, and the infrastructure available for advanced approaches. By integrating product, clinical subtype, procedural modality, patient demographics, and care setting, stakeholders can prioritize development pathways, tailor value communication, and target clinical evidence generation where it will most influence adoption.

Comprehensive regional insights illustrating how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence regulatory, clinical, and commercial strategies

Regional dynamics materially influence regulatory pathways, reimbursement environments, and clinical practice patterns, creating differentiated opportunities and constraints for market participants. In the Americas, procedural volumes and wide adoption of minimally invasive techniques coexist with payer-driven emphasis on cost-effectiveness and value-based procurement; clinicians often balance innovation adoption with demonstrable outcome improvements, and the commercial environment favors durable devices supported by robust clinical evidence and economic case studies. In Europe, Middle East & Africa, heterogeneity in regulatory regimes and healthcare funding models yields variable adoption curves: while some markets rapidly embrace advanced meshes and robotic platforms, others emphasize low-cost, reliable solutions and local manufacturing partnerships to increase access.

In the Asia-Pacific region, rising surgical capacity, expanding ambulatory services, and investment in robotic and minimally invasive capabilities are driving demand for devices tailored to diverse anatomical and clinical presentations. Regional supply chain resiliency and localized distribution strategies also shape product availability, with many companies establishing regional hubs to streamline logistics and ensure regulatory alignment. Cross-region collaboration on post-market registries and harmonized clinical protocols is increasingly important to generate transferable evidence and accelerate adoption across jurisdictions. Understanding these regional contours enables stakeholders to calibrate evidence generation, pricing strategies, and commercialization pathways in ways that respect local clinical practice and procurement realities.

Competitive and company-level insights revealing how incumbent firms and innovators align clinical evidence, supply chain strategy, and commercial models for sustained differentiation

Competitive dynamics in the hernia repair device space are defined by a mix of established medical device organizations, specialized surgical mesh companies, and agile technology-focused entrants. Market leaders typically leverage broad commercialization networks, physician relationships, and deep regulatory experience to secure formulary positions and surgical preference, while smaller innovators often compete on niche material science breakthroughs or procedural ease-of-use. Strategic behaviors among these players include targeted acquisitions to fill gaps in mesh portfolios, partnerships with clinical research consortia to accelerate evidence generation, and investment in surgeon training programs to shorten the adoption curve for novel products.

Manufacturers are also responding to changing procurement models by offering bundled service agreements, outcome-based contracting pilots, and enhanced post-market surveillance commitments to reassure payers and health systems. On the innovation front, companies are directing R&D toward coatings and hybrid constructs that mitigate infection and adhesion risks, and toward fixation solutions that reduce chronic pain without compromising durability. Supply chain considerations and regulatory pathways influence go-to-market timing, and competitive advantage often accrues to organizations that can demonstrate reproducible clinical benefits alongside operational efficiencies for providers. Ultimately, sustained differentiation will depend on combining material and device innovation with credible clinical data and flexible commercial models that meet the needs of diverse healthcare settings.

Actionable recommendations for industry leaders to align evidence generation, surgeon training, supply chain resilience, and commercial value propositions for durable competitiveness

Industry leaders should pursue a set of coordinated actions to capture clinical credibility and commercial resilience. Leaders must prioritize rigorous evidence generation that includes comparative effectiveness studies and registry-based outcomes to substantiate claims about recurrence reduction, pain mitigation, and infection resistance. Parallel investments in surgeon education and proctoring reduce practice variability and support reproducible outcomes, thereby accelerating adoption in both academic centers and community hospitals. In procurement conversations, companies should present comprehensive value dossiers that integrate clinical data, total cost of care considerations, and implementation support to address the priorities of health system decision-makers.

From an operational perspective, diversifying manufacturing footprints and strengthening logistics partnerships mitigate tariff and supply disruption risks, while modular product platforms enable faster customization across procedural approaches and patient types. Moreover, embedding digital health capabilities such as procedure documentation tools or remote follow-up platforms can enhance post-market surveillance and create stickiness with provider customers. Finally, executives should evaluate strategic collaborations with payer groups to pilot outcome-based contracting models and with academic partners to generate unbiased evidence. These combined actions will help ensure that device innovation translates into measurable clinical value and sustainable commercial performance.

Rigorous research methodology combining primary stakeholder interviews, peer-reviewed evidence synthesis, and expert validation to ensure credible, actionable insights

The research approach synthesized primary stakeholder engagement, structured literature review, and triangulation across clinical guidance and real-world practice patterns to deliver robust insights. Primary research involved structured interviews with surgeons across specialties, hospital procurement leaders, device development executives, and regulatory experts to capture operational realities, unmet clinical needs, and adoption barriers. Secondary research encompassed peer-reviewed clinical studies, professional society guidelines, regulatory filings, and publicly available safety communications, with emphasis on extracting clinically relevant findings and methodological rigor.

Data synthesis employed cross-validation techniques to reconcile divergent viewpoints and ensure findings were supported by multiple evidence streams. Quality assurance included independent review of key conclusions by clinical subject-matter experts and validation of regulatory interpretations against agency guidance documents. Ethical considerations and confidentiality agreements governed primary interviews, while transparency about analytical assumptions guided the presentation of insights. This methodology prioritizes reproducibility, stakeholder triangulation, and a balance between clinical nuance and strategic implications to inform decision-making across R&D, commercial, and procurement functions.

Conclusive synthesis emphasizing the need to integrate clinical evidence, procedural adaptability, and supply chain agility to sustain value and drive adoption

In aggregate, the hernia repair device environment is moving toward a convergence of material innovation, procedural adaptation, and value-driven commercialization. Clinicians and health systems increasingly expect devices to deliver not only safety and durability but also demonstrable improvements in patient experience and downstream resource utilization. As procedural modalities diversify across open, laparoscopic, and robotic platforms, device designs and support services must adapt to enable consistent, scalable outcomes. Meanwhile, external pressures such as tariff adjustments and supply chain volatility underscore the importance of operational agility and localized strategies.

Looking ahead, successful organizations will be those that couple technological differentiation with transparent evidence and flexible commercial models that resonate with payers and providers. Integrating clinical research, surgeon education, and supply chain foresight will be essential to navigate both regulatory expectations and evolving care delivery models. By focusing on patient-centered outcomes, reproducible techniques, and resilient operations, stakeholders can better align innovation with the practical demands of modern surgical practice and sustain long-term value creation for patients and healthcare systems alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia Repair Devices Market, by Product

  • 8.1. Fixation Devices
  • 8.2. Mesh
    • 8.2.1. Biological Mesh
    • 8.2.2. Synthetic Mesh
  • 8.3. Sutures
    • 8.3.1. Absorbable
    • 8.3.2. Non-Absorbable

9. Hernia Repair Devices Market, by Hernia Type

  • 9.1. Femoral Hernia
  • 9.2. Hiatal Hernia
  • 9.3. Inguinal Hernia
  • 9.4. Ventral Hernia
    • 9.4.1. Epigastric Hernia
    • 9.4.2. Incisional Hernia
    • 9.4.3. Umbilical Hernia

10. Hernia Repair Devices Market, by Procedure Type

  • 10.1. Laparoscopic Surgery
  • 10.2. Open Surgery
  • 10.3. Robotic Surgery

11. Hernia Repair Devices Market, by Patient Type

  • 11.1. Adult
  • 11.2. Pediatric

12. Hernia Repair Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Hernia Repair Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hernia Repair Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hernia Repair Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hernia Repair Devices Market

17. China Hernia Repair Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AbbVie Inc.
  • 18.6. Aran Biomedical by Integer Holdings Corporation
  • 18.7. B. Braun SE
  • 18.8. Baxter International Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Betatech Medical
  • 18.11. BioCer Entwicklungs-GmbH
  • 18.12. Boston Scientific Corporation
  • 18.13. Coloplast A/S
  • 18.14. CooperSurgical, Inc.
  • 18.15. Cousin Surgery
  • 18.16. Deep Blue Medical Advances, Inc.
  • 18.17. Dolphin Sutures
  • 18.18. Getinge AB
  • 18.19. HERNIAMESH S.r.l.
  • 18.20. Hwainmedi Co., Ltd.
  • 18.21. Insightra Medical Inc.
  • 18.22. Integra LifeSciences Holdings Corporation
  • 18.23. Intuitive Surgical, Inc.
  • 18.24. Johnson & Johnson Services, Inc.
  • 18.25. KATSAN Katgut Sanayi ve Tic. A.S.
  • 18.26. Medtronic PLC
  • 18.27. Meril Life Sciences Pvt. Ltd.
  • 18.28. Momentis Surgical Ltd.
  • 18.29. Novus Scientific AB
  • 18.30. Olympus Corporation
  • 18.31. Secant Group, LLC
  • 18.32. Surgimatix, Inc.
  • 18.33. TELA Bio, Inc.
  • 18.34. W. L. Gore & Associates, Inc.
  • 18.35. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA REPAIR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA REPAIR DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY NON-ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FEMORAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FEMORAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY FEMORAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HIATAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HIATAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HIATAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INGUINAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INGUINAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INGUINAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY EPIGASTRIC HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY EPIGASTRIC HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY EPIGASTRIC HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INCISIONAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INCISIONAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY INCISIONAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY UMBILICAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY UMBILICAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY UMBILICAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ROBOTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ROBOTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 162. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 163. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 165. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 189. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 190. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 192. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 198. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 199. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 201. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL HERNIA REPAIR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA HERNIA REPAIR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY HERNIA TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA HERNIA REPAIR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)